In this paper, we report a new model for EGFR internalization and degradation due to tyrosine-kinase inhibitor treatment in a 3D cell culture of pancreatic ductal adenocarcinoma cells. This evidence concerns the gene EGFR and pancreatic ductal adenocarcinoma.